Dianthus Therapeutics, Inc. Common Stock (DNTH) Financials
Key financial figures for Dianthus Therapeutics, Inc. Common Stock (Q2 2026).
- Revenue
- $761K
- Net Income
- -$50M
- EPS
- $-0.90
- Total Assets
- $1.2B
- Operating Cash Flow
- -$49M
Full income statement, balance sheet, and cash flow for Dianthus Therapeutics, Inc. Common Stock on SentiSense.